Capstone Investment Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Capstone Investment Advisors's DXCM Position: Q1 2026 in Review
Capstone Investment Advisors increased its DexCom (DXCM) stake by 5.5% in Q1 2026, buying an estimated $198K and bringing the position to 54,715 shares worth $3.44M. The position accounts for 0.01% of the portfolio, ranked #504.
Capstone Investment Advisors first reported a position in DXCM in Q4 2020 and has held it in 16 quarters since. The position peaked at $8.04M in Q3 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Capstone Investment Advisors held 54,715 shares of DexCom worth $3.44M as of Q1 2026.
- Capstone Investment Advisors bought 2,840 DexCom shares in Q1 2026, an estimated $198K.
- DexCom made up 0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #504 holding.
- Capstone Investment Advisors first reported a position in DexCom in Q4 2020 and has held it in 16 quarters since.
- Capstone Investment Advisors's DexCom position peaked at $8.04M in Q3 2025.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.